Federated Hermes’s Trevi Therapeutics TRVI Stock Holding History
Bought
Maintained
Sold
Other funds holding TRVI
Federated Hermes's TRVI Position: Q3 2026 in Review
Federated Hermes opened a new position in Trevi Therapeutics (TRVI) in Q3 2026: 773,744 shares worth $11.1M. The stake represents 0.02% of the portfolio and ranks #649 among its holdings. This is a return to the name: Federated Hermes previously reported a position in TRVI as recently as Q3 2024.
Federated Hermes first reported a position in TRVI in Q3 2022 and has held it in 6 quarters since. 223 funds tracked by Wall St. Rank hold TRVI as of Q3 2026.
- Federated Hermes held 773,744 shares of Trevi Therapeutics worth $11.1M as of Q3 2026.
- Trevi Therapeutics was a new Federated Hermes position in Q3 2026.
- Trevi Therapeutics made up 0.02% of Federated Hermes's portfolio in Q3 2026, its #649 holding.
- Federated Hermes first reported a position in Trevi Therapeutics in Q3 2022 and has held it in 6 quarters since.
- 223 funds tracked by Wall St. Rank held Trevi Therapeutics as of Q3 2026.
Based on Federated Hermes's 13F filing for Q3 2026, filed 12 Nov 2026.